118 related articles for article (PubMed ID: 38073490)
41. Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer.
Zhao J; Quan J; Chen W; Xie X
Eur J Med Res; 2023 Nov; 28(1):511. PubMed ID: 37964339
[TBL] [Abstract][Full Text] [Related]
42. Predicting survival and immune microenvironment in colorectal cancer: a STAT signaling-related signature.
Zeng R; Wu H; Qiu X; Zhuo Z; Sha W; Chen H
QJM; 2022 Sep; 115(9):596-604. PubMed ID: 34978566
[TBL] [Abstract][Full Text] [Related]
43. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
44. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
45. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
46. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
47. A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer.
Liu J; Yu F; Liu Z; Wang X; Li J
Cancer Biother Radiopharm; 2022 Dec; 37(10):963-975. PubMed ID: 34551265
[No Abstract] [Full Text] [Related]
48. A novel prognostic model based on urea cycle-related gene signature for colorectal cancer.
Guo H; Wang Y; Gou L; Wang X; Tang Y; Wang X
Front Surg; 2022; 9():1027655. PubMed ID: 36338624
[TBL] [Abstract][Full Text] [Related]
49. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive analysis of transient receptor potential channels-related signature for prognosis, tumor immune microenvironment, and treatment response of colorectal cancer.
Wang L; Chen X; Zhang H; Hong L; Wang J; Shao L; Chen G; Wu J
Front Immunol; 2022; 13():1014834. PubMed ID: 36389750
[TBL] [Abstract][Full Text] [Related]
51. A novel identified pyroptosis-related prognostic signature of colorectal cancer.
Zheng C; Tan Z
Math Biosci Eng; 2021 Oct; 18(6):8783-8796. PubMed ID: 34814322
[TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
53. Identification of a novel lymphangiogenesis signature associated with immune cell infiltration in colorectal cancer based on bioinformatics analysis.
Liu H; Shi H; Sun Y
BMC Med Genomics; 2024 Jan; 17(1):2. PubMed ID: 38167072
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of oxidative stress-related genes in colorectal cancer and its correlation with tumor immunity.
Yang L; Fang C; Zhang R; Zhou S
BMC Genomics; 2024 Jan; 25(1):8. PubMed ID: 38166604
[TBL] [Abstract][Full Text] [Related]
55. Long Noncoding RNA KCNQ1OT1 is a Prognostic Biomarker and mediates CD8
Lin ZB; Long P; Zhao Z; Zhang YR; Chu XD; Zhao XX; Ding H; Huan SW; Pan YL; Pan JH
Int J Biol Sci; 2021; 17(7):1757-1768. PubMed ID: 33994860
[No Abstract] [Full Text] [Related]
56. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
[TBL] [Abstract][Full Text] [Related]
57. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
58. Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network.
Yang ZD; Kang H
World J Gastroenterol; 2020 Mar; 26(12):1298-1316. PubMed ID: 32256018
[TBL] [Abstract][Full Text] [Related]
59. Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature.
Guo XW; Lei RE; Zhou QN; Zhang G; Hu BL; Liang YX
BMC Cancer; 2023 Aug; 23(1):773. PubMed ID: 37596528
[TBL] [Abstract][Full Text] [Related]
60. Cross-Talk Between m
Song W; Ren J; Xiang R; Yuan W; Fu T
Front Immunol; 2022; 13():740960. PubMed ID: 35350786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
